Emcure Pharmaceuticals has entered into an exclusive agreement with Sanofi India to distribute and promote its oral anti-diabetic medications, including well-known brands like Amaryl and Cetapin. The partnership aims to leverage Emcure’s expansive distribution network to strengthen market reach.